Genotoxic, Non - Genotoxic and Epigenetic Mechanisms in Chemical Hepatocarcinogenesis: Implications for Safety Evaluation

Epigenetics and Human Health: Linking Hereditary, Environmental and Nutritional Aspects

Volumn , Issue , 2010, Pages 87-103

  Bursch, Wilfried ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Chemoprevention; DNA methylation; Genotoxic and non genotoxic carcinogens; Hepatocarcinogenesis; Microenvironment; Safety evaluation

Indexed keywords

EID: 84884632615     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9783527628384.ch8     Document Type: Chapter

References (75)

1. Schulte-Hermann, R., Timmermann-Trosiener, I., Barthel, G., and Bursch, W. ( 1990 ) DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion . Cancer Res., 50, 5127-5135.
2. Schulte-Hermann, R., Bursch, W., and Grasl-Kraupp, B. ( 1995 ) Active cell death (apoptosis) in liver biology and disease. Prog. Liver Dis., 13, 1-35.
3. Olivier, M., Hussain, S.P., Caron de Fromentel, C., Hainaut, P., and Harris, C.C. ( 2004 ) TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. IARC Sci. Publ., 157, 247-270.
4. Bursch, W., Chabicovsky, M., Wastl, U., Grasl-Kraupp, B., Bukowska, K., Taper, H., and Schulte-Hermann, R. ( 2005 ) Apoptosis in stages of mouse hepatocarcinogenesis: failure to counterbalance cell proliferation and to account for strain differences in tumor susceptibility. Toxicol. Sci., 85, 515-529.
5. Schwarz, M., and Appel, K.E. ( 2005 ) Carcinogenic risks of dioxin: mechanistic considerations. Regul. Toxicol. Pharmacol., 43, 19-34.
6. Pitot, H.C. ( 2007 ) Adventures in hepatocarcinogenesis. Annu. Rev. Pathol., 2, 1-29.
7. Wong, C.M., and Ng, I.O. ( 2008 ) Molecular pathogenesis of hepatocellular carcinoma. Liver Int., 28, 160-174.
8. Klaunig, J.E., Babich, M.A., Baetcke, K.P., Cook, J.C., Corton, J.C., David, R.M., DeLuca, J.G., Lai, D.Y., McKee, R.H., Peters, J.M., Roberts, R.A., and Fenner-Crisp, P.A. ( 2003 ) PPARalpha agonist-induced rodent tumors: modes of action and human relevance. Crit. Rev. Toxicol., 33, 655-780.
9. Fairhurst, S. ( 2003 ) Hazard and risk assessment of industrial chemicals in the occupational context in Europe: some current issues. Food Chem. Toxicol., 41, 1453-1462.
10. Nordberg, A., Ruden, C., and Hansson, S.O. ( 2008 ) Towards more efficient testing strategies-analyzing the efficiency of toxicity data requirements in relation to the criteria for classification and labelling. Regul. Toxicol. Pharmacol., 50, 412-419.
11. Holsapple, M.P., Pitot, H.C., Cohen, S.M., Boobis, A.R., Klaunig, J.E., Pastoor, T., Dellarco, V.L., and Dragan, Y.P. ( 2006 ) Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol. Sci., 89, 51-56.
12. Barlow, S., Renwick, A.G., Kleiner, J., Bridges, J.W., Busk, L., Dybing, E., Edler, L., Eisenbrand, G., Fink-Gremmels, J., Knaap, A., Kroes, R., Liem, D., Muller, D.J., Page, S., Rolland, V., Schlatter, J., Tritscher, A., Tueting, W., and Wurtzen, G. ( 2006 ) Risk assessment of substances that are both genotoxic and carcinogenic report of an International Conferenceorganized by EFSA and WHO with support of ILSI Europe. Food Chem. Toxicol., 44, 1636-1650.
13. REACH ( 2007 ) Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC. Commission Regulation (EC) No 1488/94
14. Parzefall, W., and Schulte-Hermann, R. ( 2004 ) Mehrstufenkonzept der Kanzerogense und chenmischen kanzerogenese, in Die Onkologie (eds W. Hiddemann, H. Huber, R. Bartram and R. Claus ), Springer Verlag, pp. 194-240.
15. Szyf, M. ( 2007 ) The dynamic epigenome and its implications in toxicology. Toxicol. Sci., 100, 7-23.
16. Newbold, R.R., Padilla-Banks, E., and Jefferson, W.N. ( 2006 ) Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology, 147, S11-S17.
17. Skinner, M.K., and Anway, M.D. ( 2007 ) Epigenetic transgenerational actions of vinclozolin on the development of disease and cancer. Crit. Rev. Oncog., 13, 75-82.
18. Pogribny, I.P., Rusyn, I., and Beland, F.A. ( 2008 ) Epigenetic aspects of genotoxic and non-genotoxic hepatocarcinogenesis: studies in rodents. Environ Mol. Mutagen, 49, 9-15.
19. Low-Baselli, A., Hufnagl, K., Parzefall, W., Schulte-Hermann, R., and Grasl-Kraupp, B. ( 2000 ) Initiated rat hepatocytes in primary culture: a novel tool to study alterations in growth control during the first stage of carcinogenesis. Carcinogenesis, 21, 79-86.
20. Teufel, A., Staib, F., Kanzler, S., Weinmann, A., Schulze-Bergkamen, H., and Galle, P.R. ( 2007 ) Genetics of hepatocellular carcinoma. World J. Gastroenterol., 13, 2271-2282.
21. Rodgarkia-Dara, C., Vejda, S., Erlach, N., Losert, A., Bursch, W., Berger, W., Schulte-Hermann, R., and Grusch, M. ( 2006 ) The activin axis in liver biology and disease. Mutat. Res., 613, 123-137.
22. Herzer, K., Sprinzl, M.F., and Galle, P.R. ( 2007 ) Hepatitis viruses: live and let die. Liver Int., 27, 293-301.
23. IARC ( 2002 ) International Agency forResearch on Cancer (IARC)-summaries & evaluations. AFLATOXINS, 82-171.
24. Breuhahn, K., Longerich, T., and Schirmacher, P. ( 2006 ) Dysregulation of growth factor signaling in human hepatocellular carcinoma. Oncogene, 25, 3787-3800.
25. Calvisi, D.F., Pascale, R.M., and Feo, F. ( 2007 ) Dissection of signal transduction pathways as a tool for the development of targeted therapies of hepatocellular carcinoma. Rev. Recent Clin. Trials, 2, 217-236.
26. Konno, Y., Negishi, M., and Kodama, S. ( 2008 ) The roles of nuclear receptors CAR and PXR in hepatic energy metabolism. Drug Metab. Pharmacokinet., 23, 8-13.
27. EFSA ( 2005 ) Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request from the commission related to butylbenzylphthalate (BBP) for use in food contact materials. Adopted on 23 June 2005 by written procedure. EFSA J., 241, 1-14.
28. EFSA ( 2005 ) Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request from the commission related to di-isodecylphthalate (DIDP) for use in food contact materials. Adopted on 30 July 2005. EFSA J., 245, 1-14.
29. EFSA ( 2005 ) Opinion of the scientific committee on a request from EFSA related to a harmonised approach for risk assessment of substances which are both genotoxic and carcinogenic. EFSA J., 282, 1-31.
30. EFSA ( 2005 ) Opinion of the scientific panel on food additives, flavourings, processing aids and materials in contact with food (AFC) on a request from the commission related to di-isononylphthalate (DINP) for use in food contact materials. Adopted on 30 July 2005. EFSA J., 244, 1-18.
31. EFSA ( 2005 ) Statement of the scientific panel on food additives, flavourings, Processing Aids and Materials in Contact with Food on a request from the Commission on the possibility of allocating a group-TDI for butylbenzylphthalate (BBP), di-butylphthalate (DBP), bis(2-ethylhexyl) phthalate (DEHP), di-isononylphthalate (DINP) and di-isodecylphthalate (DIDP). http://www.efsa.europa.eu/EFSA/efsa_locale-1178620753812_1178620768397.htm.
32. Bursch, W., Karwan, A., Mayer, M., Dornetshuber, J., Frohwein, U., Schulte-Hermann, R., Fazi, B., Di Sano, F., Piredda, L., Piacentini, M., Petrovski, G., Fesus, L., and Gerner, C. ( 2008 ) Cell death and autophagy: cytokines, drugs, and nutritional factors. Toxicology, 254, 147-157.
33. Grasl-Kraupp, B., Bursch, W., Ruttkay-Nedecky, B., Wagner, A., Lauer, B., and Schulte-Hermann, R. ( 1994 ) Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc. Natl. Acad. Sci. U. S. A., 91, 9995-9999.
34. Mullauer, L., Grasl-Kraupp, B., Bursch, W., and Schulte-Hermann, R. ( 1996 ) Transforming growth factor beta 1-induced cell death in preneoplastic foci of rat liver and sensitization by the antiestrogen tamoxifen. Hepatology, 23, 840-847.
35. Sagmeister, S., Eisenbauer, M., Pirker, C., Mohr, T., Holzmann, K., Zwickl, H., Bichler, C., Kandioler, D., Wrba, F., Mikulits, W., Gerner, C., Shehata, M., Majdic, O., Streubel, B., Berger, W., Micksche, M., Zatloukal, K., Schulte-Hermann, R., and Grasl-Kraupp, B. ( 2008 ) New cellular tools reveal complex epithelial-mesenchymal interactions in hepatocarcinogenesis. Br. J. Cancer, 99, 151-159.
36. Majewski, N., Nogueira, V., Bhaskar, P., Coy, P.E., Skeen, J.E., Gottlob, K., Chandel, N.S., Thompson, C.B., Robey, R.B., and Hay, N. ( 2004 ) Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol. Cell, 16, 819-830.
37. Pastorino, J.G., Hoek, J.B., and Shulga, N. ( 2005 ) Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res., 65, 10545-10554.
38. Byfield, M.P., Murray, J.T., and Backer, J.M. ( 2005 ) hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase. J. Biol. Chem., 280, 33076-33082.
39. Robey, R.B., and Hay, N. ( 2006 ) Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene, 25, 4683-4696.
40. Dills, W.L. Jr., Bell, L.S., and Onuma, E.K. ( 1981 ) Inhibitory effects of substrate analogs on lactate production from fructose and glucose in bovine spermatozoa. Biol. Reprod, 25, 458-465.
41. Gottlob, K., Majewski, N., Kennedy, S., Kandel, E., Robey, R.B., and Hay, N. ( 2001 ) Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev., 15, 1406-1418.
42. Hwang, S.O., and Lee, G.M. ( 2008 ) Nutrient deprivation induces autophagy as well as apoptosis in Chinese hamster ovary cell culture. Biotechnol. Bioeng., 99, 678-685.
43. Preston, R.J. ( 2007 ) Epigenetic processes and cancer risk assessment. Mutat. Res., 616, 7-10.
44. Ushijima, T. ( 2007 ) Epigenetic field for cancerization. J. Biochem. Mol. Biol., 40, 142-150.
45. Gronbaek, K., Hother, C., and Jones, P.A. ( 2007 ) Epigenetic changes in cancer. APMIS, 115, 1039-1059.
46. Tischoff, I., and Tannapfe, A. ( 2008 ) DNA methylation in hepatocellular carcinoma. World J. Gastroenterol., 14, 1741-1748.
47. Ghoshal, A.K., and Farber, E. ( 1984 ) The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens. Carcinogenesis, 5, 1367-1370.
48. Rao, P.M., Antony, A., Rajalakshmi, S., and Sarma, D.S. ( 1989 ) Studies on hypomethylation of liver DNA during early stages of chemical carcinogenesis in rat liver. Carcinogenesis, 10, 933-937.
49. Lombardi, B., Chandar, N., and Locker, J. ( 1991 ) Nutritional model of hepatocarcinogenesis. Rats fed choline-devoid diet. Dig. Dis. Sci., 36, 979-984.
50. Feo, F., Pascale, R.M., Simile, M.M., De Miglio, M.R., Muroni, M.R., and Calvisi, D. ( 2000 ) Genetic alterations in liver carcinogenesis: implications for new preventive and therapeutic strategies. Crit. Rev. Oncog., 11, 19-62.
51. Pascale, R.M., Simile, M.M., De Miglio, M.R., and Feo, F. ( 2002 ) Chemoprevention of hepatocarcinogenesis: S-adenosyl-L-methionine. Alcohol, 27, 193-198.
52. Macheiner, D., Heller, G., Kappel, S., Bichler, C., Stattner, S., Ziegler, B., Kandioler, D., Wrba, F., Schulte-Hermann, R., Zochbauer-Muller, S., and Grasl-Kraupp, B. ( 2006 ) NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinoma. J. Hepatol., 45, 81-89.
53. Zhang, Y.J., Chen, Y., Ahsan, H., Lunn, R.M., Lee, P.H., Chen, C.J., and Santella, R.M. ( 2003 ) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma. Int. J. Cancer, 103, 440-444.
54. Zhang, Y.J., Chen, Y., Ahsan, H., Lunn, R.M., Chen, S.Y., Lee, P.H., Chen, C.J., and Santella, R.M. ( 2005 ) Silencing of glutathione S-transferase P1 by promoter hypermethylation and its relationship to environmental chemical carcinogens in hepatocellular carcinoma. Cancer Lett., 221, 135-143.
55. Tryndyak, V.P., Kovalchuk, O., Muskhelishvili, L., Montgomery, B., Rodriguez-Juarez, R., Melnyk, S., Ross, S.A., Beland, F.A., and Pogribny, I.P. ( 2007 ) Epigenetic reprogramming of liver cells in tamoxifen-induced rat hepatocarcinogenesis. Mol. Carcinog., 46, 187-197.
56. Watson, R.E., and Goodman, J.I. ( 2002 ) Effects of phenobarbital on DNA methylation in GC-rich regions of hepatic DNA from mice that exhibit different levels of susceptibility to liver tumorigenesis. Toxicol. Sci., 68, 51-58.
57. Bachman, A.N., Kamendulis, L.M., and Goodman, J.I. ( 2006 ) Diethanolamine and phenobarbital produce an altered pattern of methylation in GC-rich regions of DNA in B6C3F1 mouse hepatocytes similar to that resulting from choline deficiency. Toxicol. Sci., 90, 317-325.
58. Bachman, A.N., Phillips, J.M., and Goodman, J.I. ( 2006 ) Phenobarbital induces progressive patterns of GC-rich and gene-specific altered DNA methylation in the liver of tumor-prone B6C3F1 mice. Toxicol. Sci., 91, 393-405.
59. Phillips, J.M., and Goodman, J.I. ( 2008 ) Identification of genes that may play critical roles in phenobarbital (PB)-induced liver tumorigenesis due to altered DNA methylation. Toxicol. Sci., 104, 86-99.
60. Boobis, A.R., Doe, J.E., Heinrich-Hirsch, B., Meek, M.E., Munn, S., Ruchirawat, M., Schlatter, J., Seed, J., and Vickers, C. ( 2008 ) IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit. Rev. Toxicol., 38, 87-96.
61. Lu, S.C., and Mato, J.M. ( 2008 ) S-Adenosylmethionine in cell growth, apoptosis and liver cancer. J. Gastroenterol. Hepatol., 23 ( Suppl. 1 ), S73-S77.
62. Hasmall, S., James, N., Hedley, K., Olsen, K., and Roberts, R. ( 2001 ) Mouse hepatocyte response to peroxisome proliferators: dependency on hepatic nonparenchymal cells and peroxisome proliferator activated receptor alpha (PPARalpha). Arch. Toxicol., 75, 357-361.
63. Rose, M.L., Rusyn, I., Bojes, H.K., Belyea, J., Cattley, R.C., and Thurman, R.G. ( 2000 ) Role of Kupffer cells and oxidants in signaling peroxisome proliferator-induced hepatocyte proliferation. Mutat. Res., 448, 179-192.
64. Laskin, D.L., Robertson, F.M., Pilaro, A.M., and Laskin, J.D. ( 1988 ) Activation of liver macrophages following phenobarbital treatment of rats. Hepatology, 8, 1051-1055.
65. Kroll, B., Kunz, S., Klein, T., and Schwarz, L.R. ( 1999 ) Effect of lindane and phenobarbital on cyclooxygenase-2 expression and prostanoid synthesis by Kupffer cells. Carcinogenesis, 20, 1411-1416.
66. Urbaschek, R., McCuskey, R.S., Rudi, V., Becker, K.P., Stickel, F., Urbaschek, B., and Seitz, H.K. ( 2001 ) Endotoxin, endotoxin-neutralizing-capacity, sCD14, sICAM-1, and cytokines in patients with various degrees of alcoholic liver disease. Alcohol. Clin. Exp. Res., 25, 261-268.
67. Wheeler, M.D., Kono, H., Yin, M., Nakagami, M., Uesugi, T., Arteel, G.E., Gabele, E., Rusyn, I., Yamashina, S., Froh, M., Adachi, Y., Iimuro, Y., Bradford, B.U., Smutney, O.M., Connor, H.D., Mason, R.P., Goyert, S.M., Peters, J.M., Gonzalez, F.J., Samulski, R.J., and Thurman, R.G. ( 2001 ) The role of Kupffer cell oxidant production in early ethanol-induced liver disease. Free Radical Biol. Med., 31, 1544-1549.
68. Noji, S., Tashiro, K., Koyama, E., Nohno, T., Ohyama, K., Taniguchi, S., and Nakamura, T. ( 1990 ) Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem. Biophys. Res. Commun., 173, 42-47.
69. Luckey, S.W., and Petersen, D.R. ( 2001 ) Activation of Kupffer cells during the course of carbon tetrachloride-induced liver injury and fibrosis in rats. Exp. Mol. Pathol., 71, 226-240.
70. Chou, W.C., Jie, C., Kenedy, A.A., Jones, R.J., Trush, M.A., and Dang, C.V. ( 2004 ) Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proc. Natl. Acad. Sci. U. S. A., 101, 4578-4583.
71. Teufelhofer, O., Parzefall, W., Kainzbauer, E., Ferk, F., Freiler, C., Knasmuller, S., Elbling, L., Thurman, R., and Schulte-Hermann, R. ( 2005 ) Superoxide generation from Kupffer cells contributes to hepatocarcinogenesis: studies on NADPH oxidase knockout mice. Carcinogenesis, 26, 319-329.
72. Petersen, G., Rasmussen, D., and Gustavson, K. ( 2007 ) Study on enhancing the endocrine disruptor priority list with focus on low production volume chemicals. ENV.D.4/ETU/2005/028.
73. Waterland, R.A., and Jirtle, R.L. ( 2003 ) Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol. Cell Biol., 23, 5293-5300.
74. Anway, M.D., Leathers, C., and Skinner, M.K. ( 2006 ) Endocrine disruptor vinclozolin induced epigenetic transgenerational adult-onset disease. Endocrinology, 147, 5515-5523.
75. Zambrano, E., Martinez-Samayoa, P.M., Bautista, C.J., Deas, M., Guillen, L., Rodriguez-Gonzalez, G.L., Guzman, C., Larrea, F., and Nathanielsz, P.W. ( 2005 ) Sex differences in transgenerational alterations of growth and metabolism in progeny (F2) of female offspring (F1) of rats fed a low protein diet during pregnancy and lactation. J. Physiol., 566, 225-236.